Stepping on BioMarin's turf, PTC Therapeutics picks up PKU drug for a song
While industry-shaking M&A deals are still nowhere in sight, smaller deals by bargain shoppers continue to trickle in. PTC Therapeutics has joined the club, bagging …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.